Summary
The predictive ability of population pharmacokinetic parameters of tianeptine, obtained from a mixed effect analysis of pre-marketing pharmacokinetic studies, was evaluated using tianeptine plasma concentrations obtained during a large multi-center post-marketing surveillance study.
The mean prediction error was 7.8 ng·ml−1 and the root mean square prediction error was 52.1 ng/ml when initial estimates of population pharmacokinetic parameters were used to predict drug concentrations in one half of the post-marketing data. When the population parameters were revised to reflect the data collected in the first half of the post-marketing study, the mean prediction error was reduced to −3.2 ng·ml−1 and the root mean square prediction error was reduced to 29.5 ng·ml−1.
These results suggest that population pharmacokinetic parameters obtained from pre-marketing data may not accurately predict drug concentrations in patients receiving the drug in the post-marketing setting. Once the population parameters are updated to reflect data from the post-marketing period, the predictive ability of the database increases, but substantial variability in the prediction error remains.
Similar content being viewed by others
References
Malka R, Loo H, Ganry H, Marey C, Kamoun A (1990) Long term efficacy and clinical safety of tianeptine in depressed alcoholic patients after alcohol withdrawal. Drug Invest (4): 225–234
Loo H, Ganry H, Dufour H, Guelfi JD, Malka R, Olie JP, Scharbach H, Tignol J, Marey C, Kamoun A (1992) Long-Term Use of Tianeptine in 380 Depressed Patients. Brit J Psychiatry 160 (suppl. 15): 61–65
Grasela TH, Fielder-Kelly JB, Salvadori C, Marey C, Jochemsen R (1993) Development of a population pharmacokinetic database for tianeptine. Eur J Clin Pharmacol
Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382–389
Nicot G, Lachatre G, Gonnet C, Mallon J, Mocaer E (1986) Paired ion extraction and high performance liquid chromatographic determination of tianeptine and its metabolites in human plasma urine and tissues. J Chromatogr Biomed Appl 381: 115–126
Beal S, Sheiner LB (1980) The NONMEM System. Am Stat 34: 118
Sheiner LB, Beal SL (1981) Scientific commentary some suggestions for measuring predictive performance. J Pharmacokin Biopharmaceut 9: 503–511
Beal SL, Sheiner LB (ed) (1992) Lecture notes. A short course in population pharmacokinetic data analysis using the NONMEM system. San Francisco, CA
Sheiner LB, Benet LZ (1985) Premarketing observational studies of population pharmacokinetics of new drugs. Clin Pharmacol Therap 38: 481–487
Temple R (1983) Discussion paper on the testing of drugs in the elderly. Memorandum of the Food and Drug Administration of DHHS, Washington, DC, September 30
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grasela, T.H., Fiedler-Kelly, J.B., Salvadori, C. et al. Predictive performance of population pharmacokinetic parameters of tianeptine as applied to plasma concentrations from a post-marketing study. Eur J Clin Pharmacol 45, 123–128 (1993). https://doi.org/10.1007/BF00315492
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315492